Estimating the risk of recurrent invasive pneumococcal disease in Australia, 1991

Estimating the risk of recurrent invasive pneumococcal disease in Australia, 1991–2016

Published:2021-09 Issue:40 Volume:39 Page:5748-5756
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Malo Jonathan A.,Ware Robert S.,Lambert Stephen B.^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference37 articles.

1. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance;Moore;Lancet Infect Dis,2015

2. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study;Waight;Lancet Infect Dis,2015

3. Long-term impact of a “3 + 0” schedule for 7- and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in Australia, 2002–2014;Jayasinghe;Clin Infect Dis,2017

4. Centers for Disease Control and Prevention. Pneumococcal vaccine recommendations. Available at: https://www.cdc.gov/vaccines/vpd/pneumo/hcp/recommendations.html. Accessed 2021 August 24.

5. Public Health England. Immunisation against infectious disease: chapter 25, pneumococcal. Available at: https://www.gov.uk/government/publications/pneumococcal-the-green-book-chapter-2Accessed 2021 August 24.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Presentations and Outcomes of Children in Canada With Recurrent Invasive Pneumococcal Disease From the IMPACT Surveillance Network;Pediatric Infectious Disease Journal;2022-03-04